A new program guide, published by the Centers for Disease Control and Prevention (CDC), features the Maryland Patients, Pharmacists, Partnerships (P3) as an effective model of how health care teams that include pharmacists can improve the outcomes of patients with chronic diseases. P3 is a project initiated at the University of Maryland School of Pharmacy.
The CDC guide, Partnering with Pharmacists in the Prevention and Control of Chronic Diseases, encourages health care providers and organizations to build relationships with pharmacists.
"Physicians and pharmacists are joining forces through a number of collaborations between some of the nation's largest physician groups and retail drugstore chains," states the CDC guide. It highlights the Maryland project as a national example of how pharmacists can partner with other health care professionals to make a difference in patient care, "Similarly, Maryland's P3 Program has demonstrated an effective collaboration between the Maryland Department of Health and Mental Hygiene, the University of Maryland School of Pharmacy, the Mid-Atlantic and Virginia Business Groups on Health, the Maryland Pharmacists Association, and the Maryland General Assembly."
Magaly Rodriguez de Bittner, PharmD, CDE, FAPhA, professor and chair of the Department of Pharmacy Practice and Science and director of the Maryland P3 Program, says, "Receiving this recognition from the CDC underscores how the School of Pharmacy, the state of Maryland, the Maryland Pharmacists Association, and the Maryland P3 Program continue to shape the scope of pharmacy practice locally and nationally through the incorporation of pharmacists in the health care team."
She continues, "Our practitioners continue to pioneer new roles for pharmacists in advanced clinical practice and remain committed to a continued partnership with community, institutional, and long-term care pharmacies throughout the state and nation."